Ernesto Ang
Implications of the CVOTs in Type 2 Diabetes
New AACE ABCD Algorithm: Redefining Obesity Assessment and Care
Insulin Treatment in Elderly
Diabetes Management during Ramadan
Decoding Diabetes Endotypes A Pathway to Precision Care
Hypercortisolism in the pathogenesis of Diabetes Explained:The Noxious Nine
Spontaneous hypoglycemia: Part 6 of Hypoglycemia Series
Management and prevention of hypoglycemia:Part 5 of Hypoglycemia series
Prevalence & Clinical Impact of Hypoglycemia:Part 4 of Hypoglycemia Series:
Hypoglycemia Series : Part 3 hypoglycemia unawareness (slight modifications)
Hypoglycemia Series Part 3 Hypoglycemia Unawareness
Hypoglycemia Part 2 Symptoms and Recognition
Hypoglycemia series Part 1 What is hypoglycemia
Part 6: Insulin Transition across care settings - Inpatient Hyperglycemia: From Crisis to Control
Part 5: Insulin Therapy in Hyperglycemic Crises (DKA and HHS )
Part 4 Insulin Therapy in Critically Ill Patients- Inpatient Hyperglycemia:From Crisis to Control
Part 3 Insulin therapy in non-critically ill Inpatient
Part 2: Inpatient Glycemic Target – Inpatient Hyperglycemia: From Crisis to Control
Part I: Defining Inpatient Hyperglycemia:From Crisis Toward Control
Part 6 Fruit is forbidden? Glycemic index vs glycemic load explained
Part 5 Thin people don’t get diabetes: Busting the BMI myth
Pills vs Insulin: Which Is Safer? | Diabetes Myths (Part 4)
Is Insulin Dangerous? | Diabetes Myths Busted (Part 3)
Can Diabetes Be Reversed? | Myth-Busting Series (Part 2)
Does Sugar Cause Diabetes? | Demystifying Diabetes: Myth-Busting Series (Part 1)
Unveiling Diabetic Autonomic Neuropathy The Silent Diabetes Threat
Part 4 Conversion of Glucose to ATP
Part 3 Glucose Transporters and Enzymatic Activity
Physiology of Carbodydate and related metabolism part 2 transport across cell membrane
Physiology of Carbohydrate and Related Metabolism part 1